Müller cell-derived VEGF is a significant contributor to retinal neovascularization

Journal of Pathology

Volumn 219, Issue 4, 2009, Pages 446-454

  Bai, Yanyan ^a,b,c   Ma, Jian Xing ^a,b   Guo, Junjing ^a,b,d   Wang, Juanjuan ^a,b,e   Zhu, Meili ^a,b   Chen, Ying ^a,b   Le, Yun Zheng ^a,b,f  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c SOOCHOW UNIVERSITY   (China)

^d HARBIN MEDICAL UNIVERSITY   (China)

^e CENTRAL SOUTH UNIVERSITY   (China)

^f UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Ischaemia; M ller cells; Neovascularization; Neuron survival; VEGF

Indexed keywords

CRE RECOMBINASE; DOXYCYCLINE; OXIDIZED LOW DENSITY LIPOPROTEIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD RETINA BARRIER; CELL PROLIFERATION; CHOROID; CONTROLLED STUDY; FLUORESCENCE ANGIOGRAPHY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; ISCHEMIA; KNOCKOUT MOUSE; MORPHOLOGY; MOUSE; MUELLER CELL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETINA DEGENERATION; RETINA DEVELOPMENT; RETINA NEOVASCULARIZATION; RETINOPATHY;

ANIMALS; CAPILLARY PERMEABILITY; CELLS, CULTURED; EYE PROTEINS; HUMANS; ISCHEMIA; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; RETINA; RETINAL NEOVASCULARIZATION; RETINAL NEURONS; RETINAL VESSELS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 72249121638     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2611     Document Type: Article

References (44)

1. Stalmans I, Ng YS, Rohan R, Fruttiger M, Bouche A, Yuce A, et al. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J Clin Invest 2002;109: 327-336. (Pubitemid 34141806)
2. Haigh JJ, Morelli PI, Gerhardt H, Haigh K, Tsien J, Damert A, et al. Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling. Dev Biol 2003;262: 225-241. (Pubitemid 37194504)
3. Marneros AG, Fan J, Yokoyama Y, Gerber HP, Ferrara N, Crouch RK, et al. Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am J Pathol 2005;167:1451-1459. (Pubitemid 41541430)
4. Lashkari K, Hirose T, Yazdany J, McMeel JW, Kazlauskas A, Rahimi N. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity. Am J Pathol 2000;156:1337-1344. (Pubitemid 30660011)
5. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Med 1995;1:1024-1028.
6. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-1487.
7. Adamis AP, Miller JW, Bernal MT, D'Amico DJ, Folkman J, Yeo TK, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994;118:445-450. (Pubitemid 24307211)
8. Lopez PF, Sippy BD, Lambert HM, Thach AB, Hinton DR. Transdifferentiated retinal pigment epithelial cells are immunore-active for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1996;37:855-868. (Pubitemid 26110436)
9. Frank RN, Amin RH, Eliott D, Puklin JE, Abrams GW. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am J Ophthalmol 1996;122:393-403. (Pubitemid 26300056)
10. Blaauwgeers HG, Holtkamp GM, Rutten H, Witmer AN, Koolwijk P, Partanen TA, et al. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am J Pathol 1999;155:421-428. (Pubitemid 29370392)
11. Nishijima K, Ng YS, Zhong L, Bradley J, Schubert W, Jo N, et al. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol 2007;171:53-67. (Pubitemid 47339226)
12. Kilic U, Kilic E, Jarve A, Guo Z, Spudich A, Bieber K, et al. Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways. J Neurosci 2006;26:12439-12446. (Pubitemid 44864508)
13. Saint-Geniez M, Maharaj AS, Walshe TE, Tucker BA, Sekiyama E, Kurihara T, et al. Endogenous VEGF is required for visual function: evidence for a survival role on Müller cells and photoreceptors. PLoS ONE 2008;3:e3554.
14. Okamoto N, Tobe T, Hackett SF, Ozaki H, Vinores MA, LaRochelle W, et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol 1997;151:281-291. (Pubitemid 27283979)
15. Tobe T, Okamoto N, Vinores MA, Derevjanik NL, Vinores SA, Zack DJ, et al. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Invest Ophthalmol Vis Sci 1998;39:180-188. (Pubitemid 28040477)
16. Ohno-Matsui K, Hirose A, Yamamoto S, Saikia J, Okamoto N, Gehlbach P, et al. Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment. Am J Pathol 2002;160:711-719. (Pubitemid 34160349)
17. Lai CM, Dunlop SA, May LA, Gorbatov M, Brankov M, Shen WY, et al. Generation of transgenic mice with mild and severe retinal neovascularisation. Br J Ophthalmol 2005;89:911-916. (Pubitemid 40904820)
18. van Eeden PE, Tee LB, Lukehurst S, Lai CM, Rakoczy EP, Beazley LD, et al. Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization. Invest Ophthalmol Vis Sci 2006;47:4638-4645. (Pubitemid 46584531)
19. Shen WY, Lai CM, Graham CE, Binz N, Lai YK, Eade J, et al. Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model. Diabetologia 2006;49:1690-1701. (Pubitemid 43848108)
20. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A 1995;92:905-909.
21. Miller JW, Adamis AP, Aiello LP. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. Diabetes Metab Rev 1997;13:37-50. (Pubitemid 27213792)
22. Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 1995;113:1538-1544.
23. Stone J, Itin A, Alon T, Pe'er J, Gnessin H, Chan-Ling T, et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 1995;15:4738-4747.
24. Stone J, Chan-Ling T, Pe'er J, Itin A, Gnessin H, Keshet E. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest Ophthalmol Vis Sci 1996;37:290-299. (Pubitemid 26057055)
25. Le Y, Sauer B. Conditional gene knockout using cre recombinase. Methods Mol Biol 2000;136:477-485.
26. Ueki Y, Ash JD, Zhu M, Zheng L, Le Y. Expression of Cre recombinase in retinal Müller cells. Vision Res 2009;49:615-621.
27. Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L, et al. VEGF is required for growth and survival in neonatal mice. Development 1999;126:1149-1159. (Pubitemid 29182112)
28. Das AV, Mallya KB, Zhao X, Ahmad F, Bhattacharya S, Thoreson WB, et al. Neural stem cell properties of Müller glia in the mammalian retina: regulation by Notch and Wnt signaling. Dev Biol 2006;299:283-302. (Pubitemid 44550105)
29. Le Y, Ash JD, Al-Ubaidi MR, Chen Y, Ma J, Anderson RE. Targeted expression of Cre recombinase to cone photoreceptors in transgenic mice. Mol Vis 2004;10:1011-1018. (Pubitemid 41358190)
30. Quiambao AB, Peachey NS, Mangini NJ, Rohlich P, Holly- field JG, al-Ubaidi MR. A 221-bp fragment of the mouse opsin promoter directs expression specifically to the rod photoreceptors of transgenic mice. Vis Neurosci 1997;14:617-625. (Pubitemid 27415993)
31. Xu X, Quiambao AB, Roveri L, Pardue MT, Marx JL, Rohlich P, et al. Degeneration of cone photoreceptors induced by expression of the Mas1 protooncogene. Exp Neurol 2000;163:207-219. (Pubitemid 30314376)
32. Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB. Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci 2004;45:3330-3336. (Pubitemid 39121873)
33. Le Y. Computer-assisted semi-quantitative analysis of mouse choroidal density. Adv Exp Med Biol 2010;664:(in press).
34. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994;35:101-111.
35. Browning J, Wylie CK, Gole G. Quantification of oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1997;38:1168-1174.
36. Banin E, Dorrell MI, Aguilar E, Ritter MR, Aderman CM, Smith AC, et al. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification. Invest Ophthalmol Vis Sci 2006;47:2125-2134. (Pubitemid 46768297)
37. Chen J, Connor KM, Aderman CM, Smith LE. Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest 2008;118:526-533. (Pubitemid 351206543)
38. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994;35:101-111.
39. Le YZ, Zheng W, Rao PC, Zheng L, Anderson RE, Esumi N, et al. Inducible expression of cre recombinase in the retinal pigmented epithelium. Invest Ophthalmol Vis Sci 2008;49:1248-1253.
40. Kaur C, Sivakumar V, Foulds WS. Early response of neurons and glial cells to hypoxia in the retina. Invest Ophthalmol Vis Sci 2006;47:1126-1141. (Pubitemid 46768349)
41. Jiang J, Xia XB, Xu HZ, Xiong Y, Song WT, Xiong SQ, et al. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF. J Cell Physiol 2009;218:66-74.
42. Antonetti DA, Barber AJ, Hollinger LA, Wolpert EB, Gardner TW. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem 1999;274:23463-23467. (Pubitemid 129529185)
43. Cepko CL, Austin CP, Yang X, Alexiades M, Ezzeddine D. Cell fate determination in the vertebrate retina. Proc Natl Acad Sci U S A 1996;93:589-595. (Pubitemid 26041133)
44. Ueno S, Pease ME, Wersinger DM, Masuda T, Vinores SA, Licht T, et al. Prolonged blockade of VEGF family members does not cause identifiable damage to retinal neurons or vessels. J Cell Physiol 2008;217:13-22.